Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 120103 | AGI-5198 | 1355326-35-0 | 98% |  |
| AGI-5198 is a novel R132H-IDH1 inhibitor, identified through a high-throughput screen | ||||
| 122203 | Dalcetrapib | 211513-37-0 | 98% |  |
| Dalcetrapib is a rhCETP inhibitor with IC50 of 0.2 M that increases the plasma HDL ch | ||||
| 122518 | SB-742457 ( Intepirdine ) | 607742-69-8 | 98% | _607742-69-8.png) |
| SB-742457(Intepirdine) is a highly selective 5-HT6 receptor antagonist with pKi of 9. | ||||
| 122524 | GW2580 | 870483-87-7 | 98% |  |
| GW2580 is an orally bioavailable inhibitor of c-FMS kinase; completely inhibited huma | ||||
| 122805 | Balipodect ( TAK-063 ) | 1238697-26-1 | 98% | _1238697-26-1.png) |
| Balipodect (TAK 063 ) is a novel PDE10A inhibitor. It has shown high inhibitory activ | ||||
| 122919 | Tenapanor | 1234423-95-0 | 98% |  |
| Tenapanoris an inhibitor of the sodium-proton exchanger NHE3. Thisantiporter protein | ||||
| 122941 | Pacritinib ( SB1518 ) | 937272-79-2 | ≧98.0% | _937272-79-2.png) |
| Pacritinib(SB1518) is a highly selective kinaseinhibitorwith specificity for JAK2, FL | ||||
| 51627 | MK7622 | 1227923-29-6 | 98% by HPLC |  |
| MK-7622isused as adjunctive therapy to acetylcholinesterase inhibitors (AChEIs) for t | ||||
| 20267 | Almonertinib | 1899921-05-1 | 98% Min. |  |
| Almonertinib is an orally available inhibitor of the epidermal growth factor receptor | ||||
| 10403 | CAY 10566 | 944808-88-2 | ≧98.0% |  |
| CAY 10566 is a potent selective SCD-1 inhibitor. | ||||
| 25152 | Avutometinib ( Synonyms: Ro 5126766; CH5126766 ) | 946128-88-7 | ≧98.0% |  |
| Avutometinib ( Synonyms: Ro 5126766; CH5126766 )is a potent and selective dual RAF/ME | ||||
| 011813 | Avoralstat | 918407-35-9 | 95.0% |  |
| Avoralstat (formerly BCX4161) is a potent small-molecule oral plasma kallikrein inhib | ||||